Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Associated Tumors

Co-Chairs Concetta (Connie) DiDomenico, RN, MSN, PNP-BC, CPHON, and Michael J. Fisher, MD, discuss neurofibromatosis type 1 in this CME/CNE activity titled "Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1, Plexiform Neurofibromas, and Optic Pathway Gliomas: Improving Patient Outcomes With an Innovative Therapeutic Approach." For the full presentation, downloadable Practice Aids and slides, complete CME/CNE information, and to apply for credit, please visit us at PeerView.com/BQF865. CME/CNE credit will be available until September 23, 2021.